Infectious Disease Board Review - Home Study Course

The Infectious Disease Board Review Home Study Course is an online self-paced home study program that delivers multiple study tools for individuals preparing for the American Board of Internal Medicine (ABIM) Infectious Disease certification/recertification exam. The course content is optimized for 24/7 studying on the go from any computer, smart phone, tablet, or mobile device.
 
Learners not taking the board exam will find the course provides a comprehensive and practical update on common topics and challenges in infectious diseases.
 
The course includes unlimited 12-month access to:
 
  • 65 lectures of exam-focused content patterned after the ABIM blueprint (recorded at the 2020 IDBR live course)
  • 4 – Online Only Lectures
  • 8 – Online Primers and Study Guides
  • 500 interactive case-based board prep and photo-based questions to test your exam readiness
  • Mobile course app for offline access to presentations
  • Comprehensive PDF Syllabus
 
Release Date: June 15, 2020
 

Pass Guarantee 

 
If you do not pass the ABIM MOC or Certification Exam in infectious disease after completing the IDBR Home Study Course, you may attend a live IDBR Board Review Course within twelve months of your ABIM notification date, subject to space availability, and not pay the registration fee, or you may receive access to a current IDBR Home Study Course. For more information, email idbr@gwu.edu a copy of the ABIM notification letter of your test results with the course option you are choosing.
 
Copyright Information 
 
©2020, Infectious Disease Board Review, LLC
 

Target Audience

 
This course is intended for infectious diseases physicians and fellows-in-training who are preparing for initial board certification or a maintenance of certification assessment, or those who are seeking an in-depth review of infectious diseases.
 
The content will also benefit internists, hospitalists, pharmacists, physician assistants, and nurses who manage infectious disease patients.

Learning Objectives

 
At the conclusion of this activity, participants will be able to:
 
  • Identify gaps in infectious diseases medical knowledge where further study is needed for board preparation and patient management
  • Improve confidence for taking the initial certification exam or one of the maintenance of certification assessment options
  • Identify strategies for integrating diagnostic results and patient symptoms to accurately diagnose infectious diseases
  • Recommend appropriate treatment options for infectious disease patients
  • Assess risk, determine prognosis, and apply principles from epidemiologic studies
  • Identify best-practice guidelines to incorporate into the care of infectious disease patients
  • Answer questions written in the specific format used by the ABIM for the certification and recertification examinations
Course summary
Course opens: 
03/26/2020
Course expires: 
12/31/2021
Cost:
$1,100.00
Rating: 
0

Recorded Lectures 

Day 1

Clinical Immunology and Host Defense     
Steven Holland, MD
 
Respiratory Viral Infections including Influenza, Immunocompetent, and Immunocompromised Patients
Andrew Pavia, MD
 
Management of HIV-Associated Opportunistic Infections I        
Henry Masur, MD
 
Herpes Viruses: HSV and VZV in Immunocompetent and Immunocompromised Hosts
Richard Whitley, MD
 
Penicillin Allergies    
Sandra Nelson, MD
 
Board Review Session 1       
Drs. Masur (Moderator), Bennett, Bloch, Chambers, Gandhi, Nelson, and Pavia
 
Bone and Joint Infections   
Sandra Nelson, MD
 
Syndromes that Masquerade as Infections
Karen Bloch, MD
 
Endocarditis of Native and Prosthetic Devices, and Infections of Pacers Ventricular Assist Devices
Michael Scheld, MD
 
Staphylococcal Diseases
Henry Chambers, MD
 
Pharyngitis Syndromes including Group A Strep Pharyngitis     
Karen Bloch, MD
 
Opportunity I: Photos and Questions to Test Your Board Preparation  
Rajesh Gandhi, MD
 

Day 2

 
Sexually Transmitted Infections: Genital Ulcers Diseases (GUD)
Khalil Ghanem, MD
 
Herpes Viruses in Immunocompetent and Immunosuppressed Patients; CMV, EBV, HHV 6, HHV 8
John Gnann, MD
 
Sexually Transmitted Infections: Other Diseases and Syndromes          
Khalil Ghanem, MD
 
Fungal Diseases in Normal and Abnormal Hosts   
John Bennett, MD
 
Board Review Session 2       
Drs. Whitley (Moderator), Dhanireddy, Dorman, Ghanem, Gnann, Thomas, and Tunkel
 
Encephalitis including West Nile and Rabies         
Allan Tunkel, MD
 
Domestic, Travel, and Occupational           
Shireesha Dhanireddy, MD
 
Acute Hepatitis         
David Thomas, MD
 
Chronic Hepatitis      
David Thomas, MD
 
Viral and Bacterial Meningitis          
Allan Tunkel, MD
 
Tuberculosis in Immunocompetent and Immunosuppressed Hosts       
Susan Dorman, MD
 
Brain Abscess, Cavernous Sinus Thrombosis, and Subdural and Epidural Empyema      
Allan Tunkel, MD
 

COURSE DIRECTORS 

John Bennett, MD*
Bethesda, Maryland
 
Henry Masur, MD*
Bethesda, Maryland
 

CO-DIRECTORS 

Paul Auwaerter, MD
Clinical Director, Division of Infectious Diseases, Johns Hopkins Hospital
Professor of Medicine, Johns Hopkins University School of Medicine
Baltimore, Maryland
               
David Gilbert, MD
Chief of Infectious Diseases, Providence Portland Medical Center
Director, Earle A. Chiles Research Center, Providence Portland Medical Center
Professor of Medicine, Oregon Health & Science University
Portland, Oregon
               
Roy Gulick, MD, MPH
Professor of Medicine, Weill Cornell Medical College
Chief, Division of Infectious Diseases, Weill Cornell Medical College
Gladys and Roland Harriman Professor of Medicine, Weill Cornell Medical College
New York, New York
               
Andrew Pavia, MD
Chief, Division of Pediatric Infectious Diseases, University of Utah Health Sciences Center
George and Esther Gross Presidential Professor, University of Utah School of Medicine
Salt Lake City, Utah
               
Michael Scheld, MD
Director, Pfizer Initiative in International Health, University of Virginia Health System
Bayer-Gerald L. Mandell Professor of Infectious Diseases, University of Virginia Health System
Charlottesville, Virginia
               
Richard Whitley, MD
Co-Director, Pediatric Infectious Diseases, Children’s Hospital of Alabama
Loeb Eminent Scholar Chair in Pediatrics, Distinguished Professor of Pediatrics,
Professor of Microbiology, Medicine, and Neurosurgery,
University of Alabama at Birmingham
Birmingham, Alabama
 

FACULTY 

Barbara D. Alexander, MD, MHS
Director, Transplant Infectious Diseases Service, Duke University Medical Center
Associate Professor of Medicine and Pathology, Duke University School of Medicine
Durham, North Carolina
 
David M. Aronoff, MD, FIDSA
Professor & Addison B. Scoville Jr. Chair in Medicine
Director, Division of Infectious Diseases
Vanderbilt University Medical Center Nashville, Tennessee
 
Taison Bell, MD
Assistant Professor of Medicine, School of Medicine, University of Virginia
Charlottesville, Virginia
 
Karen Bloch, MD
Associate Professor, Division of Infectious Diseases
Vanderbilt University Medical Center
Nashville, Tennessee
 
Helen Boucher, MD
Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts
 
Henry F. Chambers, MD
Professor of Medicine, University of California San Francisco
Chief, Division of Infectious Diseases, San Francisco General Hsopital
Professor of Medicine, University of California San Francisco
San Francisco, California
 
Shireesha Dhanireddy, MD
Assistant Medical Director, Madison Clinic
Harborview Medical Center
Seattle, Washington
 
Susan Dorman, MD
Professor, Division of Infectious Diseases
College of Medicine, Medical University of South Carolina
Charleston, South Carolina
 
Herbert DuPont, MD
Chief, Internal Medicine
The University of Texas-Houston Medical School
Houston, Texas
 
Rajesh Gandhi, MD
Director, HIV Clinical Services and Education, Massachusetts General Hospital
Director, Harvard Center for AIDS Research Clinical Core, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School
Boston, Massachusetts
 
Khalil G. Ghanem, MD, PhD
Deputy Director of Education, Department of Medicine
Johns Hopkins Bayview Medical Center
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
 
John Gnann, MD
Professor, College of Medicine
Charleston, South Carolina
 
Steven M. Holland, MD *
Bethesda, Maryland
 
Frank Maldarelli, MD, PhD *
Bethesda, Maryland
 
Kieren A. Marr, MD
Director, Transplant and Oncology Infectious Diseases, John Hopkins University School of Medicine
Professor of Medicine and Oncology, John Hopkins University School of Medicine
Baltimore, Maryland
 
Edward Mitre, MD
Professor, Department of Microbiology and Immunology
Uniformed Services University of the Health Sciences
Bethesda, Maryland
 
Sandra Nelson, MD
Massachusetts General Hospital
Boston, Massachusetts
 
Robin Patel, MD
Chair, Division of Clinical Microbiology
Consultant, Divisions of Clinical Microbiology and Infectious Diseases
Professor of Medicine and Microbiology, Mayo Clinic
Rochester, Minnesota
 
Michael S. Saag, MD
Director, Center for AIDS Research, University of Alabama at Birmingham
Professor of Medicine, Director of UAB CFAR, Jim Straley Chair in AIDS Research, University of Alabama at Birmingham
Birmingham, Alabama
 
David L. Thomas, MD, MPH
Chief of Infectious Diseases, Johns Hopkins School of Medicine
Stanhope Bayne Jones Professor of Medicine, Johns Hopkins University School of Medicine
Baltimore, Maryland
 
Allan R. Tunkel, MD, PhD
Associate Dean, Warren Alpert Medical School of Brown University
Providence, Rhode Island
 
Robert A. Weinstein, MD
Department of Medicine, Cook County Hospital
The C. Anderson Hedberg, M.D. Professor of Internal Medicine
Rush University Medical Center
Chicago, Illinois
 
Kevin Winthrop, MD, MPH
Associate Professor of Infectious Diseases, Ophthalmology
Professor of Public Health and Preventive Medicine
Division of Infectious Diseases, OHSU
Portland, Oregon
 
*Individual employees of the National Institutes of Health (NIH) have participated in the planning and development of the course, although the NIH is not an official sponsor. The views expressed by the participants do not necessarily represent the opinions of the NIH, DHHS, or the Federal Government.

Physician CME Credit

 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The George Washington University School of Medicine and Health Sciences and the Infectious Disease Board Review, LLC. The George Washington University School of Medicine and Health Sciences is accredited by the ACCME to provide continuing medical education for physicians.
 
The George Washington University School of Medicine and Health Sciences designates this enduring material for a maximum of 101 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

MOC Statement


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 101 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 

Pharmacist Credit

 
The George Washington University Hospital, Department of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of pharmacy education.
 
Initial Release Date:
 TBA           
Planned Expiration Date:
 TBA
UAN
 TBA
 

Learning Objectives

 
At the completion of this activity, the participant will be able to:
  • Review microbiology of pathogenic diseases
  • Review immunology of infectious diseases
  • Review state of the art clinical practice for specialty of infectious diseases
  • Discuss causes, diagnosis and treatment of infectious diseases
  • Discuss diagnosis and treatment of HIV/AIDS
  • Discuss diagnosis and treatment of fungal infections
This knowledge-based course is approved for 4.3 CE hours for pharmacists. CE credits will be transmitted electronically to NABP within 30 days.
 

Physician Assistants


PAs may claim a maximum of 101 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 

Nurse Practitioners
 

For the purposes of recertification, AANPCB accepts AMA PRA Category 1 Credit™ issued by organizations accredited by ACCME as an equivalent number of hours of participation.
 

All Other Healthcare Professionals 

 

Certificates of attendance will be provided to attendees who cannot accept AMA PRA Category 1 Credits.
 
Status
Price
Title
$1,100.00Included
Please login or register to take this course.

Price

Cost:
$1,100.00
Please login or register to take this course.